August 18, 2017

Mitch Baruchowitz Shares Merida Capital’s Three Key Cannabis Investing Criteria​​

As a sprout stage investor focused solely on ancillary investments in the cannabis industry, Merida Capital Partners looks for successful companies entering the hyper-growth stage of their lifecycle, and works to supercharge that growth while helping to build necessary corporate infrastructure, rational capital suppor...

August 7, 2016

How Maryland Perfectly Demonstrates Why Cannabis Is A Historically Unique Industry

Ahead of the launch of the Maryland medical cannabis industry and awarding of grower, processing and dispensary licenses, Mitchell Baruchowitz (Managing Partner, Merida Capital Partners) makes a case for the historical uniqueness of the burgeoning cannabis industry and today's requirement that potential entrep...

October 30, 2015

What the Surge In Public Cannabis Equities Is Telling Us About the Future of Cannabis

Mitchell Baruchowitz (Managing Partner, Merida Capital Partners), Kristin Fox (Editor in Chief, MJINews) and Glenn Taylor (former Group President, Medco, which sold to Express Scripts in 2013 for $29 Billion) discuss the welcome validation by September's Cowen and Company report, "The The Cannabis Compendium: Cros...

Please reload

Featured Posts

Investing in Cannabis: Mitch Baruchowitz

May 21, 2019

1/10
Please reload

Archive
Please reload

Have a question? Want to learn more?

641 Lexington Avenue, Suite 1801, New York, NY  10022

©2019 Merida Capital Partners. Proudly created by Rapid Fig with Wix.com